Condition

Solid Tumours clinical trials and research

• 14Clinical trials
• 1NIH research projects
• 23Countries

Newest Solid Tumours clinical trials

All recruiting trials (14)

• Testing how well different doses of BI 4060107 are tolerated in adults with unresectable advanced solid tumours

  This trial tests different dose levels of BI 4060107 to see which dose patients with advanced solid tumours can tolerate.

  Recruiting at 3 sites Phase 1 Aimedbio · Irving, Texas and 5 other locations · NCT07827144

• Testing different dose levels of BI 3822971 in adults with advanced solid tumors

  A single-arm early-phase trial is testing how well BI 3822971 is tolerated in adults with advanced or metastatic solid cancers who have exhausted standard therapies.

  Recruiting at 5 sites Phase 1 Boehringer Ingelheim · Leuven and 10 other locations · NCT07744152

• GEN1119 in people with solid tumors

  This phase 1 trial tests GEN1119 in adults with solid cancers to see if it is safe and how it behaves in the body and may show signs of activity against tumors.

  Recruiting at 8 sites Phase 1 Genmab · Rennes, Ille Et Vilaine and 7 other locations · NCT07695831

• AZD4956 alone or with saruparib for advanced HRR-deficient solid tumors

  This will test AZD4956 by itself and together with saruparib in people who have advanced or metastatic solid tumors with homologous recombination repair defects.

  Recruiting at 14 sites Phase 1/2 AstraZeneca · New York, New York and 18 other locations · NCT07446855

• Subcutaneous durvalumab plus hyaluronidase dose-finding and safety for solid tumors

  This study will test whether a subcutaneous (under-the-skin) injection of durvalumab with hyaluronidase gives similar blood levels and is safe for people with certain advanced solid tumors, including unresectable liver cancer and specific forms of lung cancer.

  Recruiting at 14 sites Phase 1 AstraZeneca · Fitzroy and 18 other locations · NCT07391670

• Different doses of BI 3810944 for adults with advanced solid tumors

  This trial tests different doses of the experimental drug BI 3810944 to see if adults with advanced solid tumours, including melanoma, who have not had success with standard treatments can tolerate it and might benefit.

  Recruiting at 5 sites Phase 1 Boehringer Ingelheim · Louisville, Kentucky and 6 other locations · NCT07224425

• AP601 infusions for unresectable advanced or metastatic solid tumors

  This study will give AP601 by infusion every two weeks to see if it is safe and may help people with advanced or metastatic solid tumors who have not responded to standard treatments.

  Recruiting Phase 1 AP Biosciences Inc. · Waratah, New South Wales and 2 other locations · NCT07165067

• First-in-human testing of BMS-986517 in advanced solid tumors

  This trial will test the experimental drug BMS-986517 in adults with advanced, unresectable or metastatic solid tumors such as non-small cell lung cancer, head and neck cancer, and certain breast cancers.

  Recruiting at 14 sites Phase 1/2 Bristol-Myers Squibb · Irvine, California and 19 other locations · NCT07160725

• Evaluating RC220 with Doxorubicin for Advanced Solid Tumours

  This study is testing a new treatment called RC220, both alone and with doxorubicin, to see if it is safe and works for adults with advanced solid tumors.

  Recruiting at 5 sites Phase 1 Racura Oncology Ltd · Gosford, New South Wales and 8 other locations · NCT06815575

• Investigating OKN4395 and Pembrolizumab for Solid Tumors

  This study is testing a new drug called OKN4395, alone and with another drug called pembrolizumab, to see if it can help people with solid tumors who have run out of other treatment options.

  Recruiting at 10 sites Phase 1 Epkin · Beverly Hills, California and 9 other locations · NCT06789172

• First-in-human trial of ODM-212 for advanced solid tumors

  This study is testing a new treatment called ODM-212 to see if it can help people with advanced solid tumors that can't be cured.

  Recruiting at 20 sites Phase 1/2 Orion Corporation, Orion Pharma · Los Angeles, California and 19 other locations · NCT06725758

• Testing Zongertinib for Advanced Cancers with HER2 Alterations

  This study is testing if a new drug called zongertinib can help adults with advanced cancers that have specific HER2 changes, especially after other treatments haven't worked.

  Recruiting at 81 sites Phase 2 Boehringer Ingelheim · Anchorage, Alaska and 92 other locations · NCT06581432

• Using atezolizumab to treat cancers with high mutation rates or specific genetic deficiencies

  This study is testing if atezolizumab can help treat adults and kids with certain types of cancers that have a lot of genetic changes or specific genetic issues.

  Recruiting at 23 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT05770102

• Collecting tissue samples to understand solid tumors better

  This study is collecting tissue samples from cancer patients to see how solid tumors work and why some treatments don't always work, with the hope of finding better therapies in the future.

  Recruiting Queen Mary University of London · London · NCT03572192

NIH-funded research (1)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Developing new treatments for childhood solid tumors

  This study is working on new ways to treat tough childhood cancers by targeting specific proteins that help the tumors grow, using advanced techniques to find and stop these proteins, all with the goal of helping kids get better.

  NIH research The Institute of Cancer Research: Royal Cancer Hospital · London, United Kingdom · NIH-11059609

Related topics

Quick answers

How many Solid Tumours clinical trials are recruiting right now?

14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 23 countries. The most sites are in Australia (7 trials), United States (7 trials), Spain (6 trials), United Kingdom (6 trials), South Korea (5 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 8, Phase 1/2: 3, Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →